DCTD Programs
DCTD Staff Present at the 2018 EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
DCTD staff presented research at the 30th EORTC-NCI-AACR Symposium on Molecular Targets and Cancer Therapeutics
(November 13-16, 2018; Dublin, Ireland). The European Organisation for Research and Treatment of Cancer (EORTC), NCI, and the American Association for Cancer Research (AACR) co-hosted the meeting. DCTD's Director, James H. Doroshow, MD, was an Organizing Committee Co-Chair, along with James Gulley, MD, PhD, NCI's Center for Cancer Research.
Authors | Title |
---|---|
Tuesday, November 13, 2018 | |
K Kalinsky, F Hong, CK McCourt, JC Sachdev, EP Mitchell, JA Zwiebel, LA Doyle, LM McShane, S Li, RJ Gray, LV Rubinstein, D Patton, PM Williams, SR Hamilton, BA Conley, PJ O'Dwyer, LN Harris, CL Arteaga, AP Chen, KT Flaherty |
Plenary Session AZD5363 in Patients (Pts) with Tumors with AKT Mutations: NCI-MATCH Subprotocol EAY131-Y, A Trial of the ECOG-ACRIN Cancer Research Group (EAY131-Y) |
Wednesday, November 14, 2018 | |
T Kinsella, H Safrani, R Breakstone, L Anderson, C Kunos, J Collins |
Plenary Session Pharmacology of Oral (PO) Ropidoxuridine in Treating Patients with Advanced Gastrointestinal Cancer Undergoing Radiation Therapy (RT) (NCT02381561) |
G O'Sullivan Coyne, SM Steinberg, IB Turkbey, G Lee, A Lih, L Machado-Pichardo, LR Folio, S Kummar, A Chen |
Poster Session: Clinical Methodology Exploratory Multi-Dimensional Assessments of Tumor Response in Desmoid Tumors: Alternatives to RECIST |
B O'Keefe, C Thornburg, J Britt, J Evans, R Akee, J Whitt, S Trinh, M Harris, J Thompson, T Ewing, S Shipley, P Grothaus, D Newman, J Schneider, T Grkovic |
Poster Session: Drug Screening The NCI Program for Natural Product Discovery: A New Resource for Cancer Drug Discovery |
Late-Breaking Abstract | |
Y Evrard, SY Alcoser, S Borgell, J Carter, L Chen, M Crespo-Eugeni, B Das, V Datta, R Divelbiss, M Gottholm-Ahalt, S Hoffman, C Karlovich, D Newton, R Patidar, L Rubinstein, H Stotler, D Trail, PM Williams, M Hollingshead, JH Doroshow |
Poster Session: Late-Breaking Preclinical Studies with Models from the National Cancer Institute's Patient-Derived Models Repository (PDMR) |